NEW YORK (GenomeWeb) – Non-invasive cancer detection firm Freenome has presented a new set of data from its early efforts using machine learning to investigate signatures in cell-free DNA that can detect cancer in otherwise healthy individuals.

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.